SAN DIEGO, May 22, 2014 (GLOBE NEWSWIRE) -- At the Paris Course on Revascularization (“EuroPCR”) being held this week in Paris, France, REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) sponsored a symposium entitled, Advancing Bioresorbable Scaffolds through Innovative Biomaterials, where information regarding the Company’s proprietary technology and bioresorbable scaffold programs was presented. The symposium was chaired by Dr. Alexandre Abizaid, Director of Invasive Cardiology at Institute Dante Pazzanese of Cardiology, in Sao Paulo, Brazil, and featured three separate presentations.
Help employers find you! Check out all the jobs and post your resume.
